| Turcja | Austria | Hiszpania | |
| Konsultacja online z onkologiem | od 211 € | - | od 400 € |
Państwo nie płacą za usługi Bookimed. Ceny na konsultację online z onkologiem na stronie odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w przeprowadzaniu konsultacji online z onkologiem. Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Nie będą Państwo sami w innym kraju podczas procedury Konsultacja online z onkologiem.
Quiron Madrid (Szpital Quiron Madrid) — wiodąca klinika w Hiszpanii i Europie, największa w sieci Quironsalud pod względem liczby pacjentów rocznie.
Specjalizacja — onkologia, neurochirurgia, kardiochirurgia, chirurgia plastyczna i in vitro.
W szpitalu Quiron Madrid prowadzone są badania w zakresie leczenia raka i zaburzeń neurodegeneracyjnych (choroba Alzheimera, Parkinsona, Huntingtona). Jeśli pacjenci spełniają kryteria, mogą za darmo poddać się leczeniu w ramach badań.
HM Hospitales — to grupa 7 wiodących hiszpańskich klinik zlokalizowanych w Madrycie (Hiszpania).
Specjalizacja — onkologia dorosłych i dzieci, neurologia, neurochirurgia, kardiologia i ortopedia.
W 2018 roku 5 spośród 7 szpitali znalazło się w TOP najlepszych prywatnych klinik w Hiszpanii według Organizacji Monitorowania Reputacji Medycznej MERCO.
Corocznie chirurdzy HM wykonują ponad 26 000 operacji, a leczenie raka przechodzi tutaj około 2 500 pacjentów.
Hospital HM Sanchinarro is a private multi-specialty medical center located in Madrid, Spain. The clinic's team specializes in neurosurgery, oncology, urology, and surgery. Hospital HM Sanchinarro serves only adults. 400,000 patients choose Hospital HM Sanchinarro to get medical care every year. They are mainly patients from Europe & Commonwealth, Arab League States, and Russian-speaking countries.
Clinica Universidad de Navarra (CUN) is the best private Spanish hospital in 2018 according to MERCO (monitoring organization of medical reputation).
Navarra is a leading sarcoma center. 74% of patients get cured of bone sarcoma; and in up to 95% of cases, an affected limb is preserved.
Oncology, Onco-Hematology, Organ Transplant, Neurosurgery, Cardiac Surgery are the primary specialties in Navarra Hospital.
Hospital de Navarra is the 1st in Spain that has received JCI, the US certificate for the high quality of medical services.
Over 700,000 patients from 70 countries have been treated at Navarra.
Klinika HM Nou Delfos to kompleksowe centrum medyczno-chirurgiczne w Barcelonie, które jest częścią największej sieci w Hiszpanii – HM Hospitals. HM Delfos specjalizuje się w chirurgii, onkologii, ortopedii, kardiologii, ginekologii, urologii, neurologii, w tym w diagnostyce i leczeniu padaczki. Klinika jest wyposażona w najnowocześniejsze urządzenia do diagnostyki i leczenia: EOS do obrazowania układu mięśniowo-szkieletowego o wysokiej precyzji, CT i MRI, dwa urządzenia do radioterapii guzów bez operacji.
Klinika posiada także umowę z Instytutem Guttmann, szpital neurorehabilitacyjny z JCI, AQU Catalunya oraz certyfikatami jakości ISO w zakresie rehabilitacji.
Dr. Lana Bijelic is a board-certified oncological surgeon. She specializes in peritoneal carcinomatosis. Since 2019, she has been part of the Carcinomatosis Surgical Group at the Teknon Oncology Institute. She trained under Prof. Paul Sugarbaker at Washington Hospital Center and brings strong expertise to her team.
Dr. Bijelic has worked as Research Director at Inova Fairfax Hospital. She has also been an associate professor at Virginia Commonwealth University and Georgetown University. She is an active member of the American College of Surgeons and the Society of Surgical Oncology.
Throughout her career, Dr. Bijelic has received many academic awards, including several Surgical Excellence Awards and top prizes in research. She is known for her leadership and important contributions to surgical oncology.
Dr. Francesc Graus is a neurologist with expertise in paraneoplastic neurological syndromes, gliomas, and primary brain lymphomas. He established the first strict diagnostic criteria for paraneoplastic syndromes. He also identified important antibodies that are now used in diagnosis. His research showed the link between tumors and autoimmune neurological attacks.
Dr. Graus earned his MD and PhD from Universitat Autònoma de Barcelona. He completed his neurology residency in Barcelona and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. He is an Emeritus investigator at IDIBAPS. He founded and served as president of the European Association of Neuro-Oncology. He is also the former chief of neurology at Hospital Clinic Barcelona.
Dr. Enriqueta Felip is an expert in thoracic oncology. She specializes in lung cancer care and clinical trials. She earned her medical degree and PhD from UAB. Dr. Felip has led research on improving chemotherapy, developing new therapies, using immunotherapy, and understanding resistance to targeted treatments.
She served as a board member of the IASLC from 2017 to 2021 and was Vice-President of SEOM from 2019 to 2021. In 2015, she received the first ESMO Women for Oncology Award. Dr. Felip has written many peer-reviewed articles and book chapters. She is known for her leadership in international oncology societies and clinical research.
Dr. Jesus Soberino is an oncologist at Vall d’Hebron University Hospital and the Vall d’Hebron Institute of Oncology (VHIO). He specializes in breast cancer and melanoma. Dr. Soberino has led many phase 1–3 clinical trials. His work has helped approve important drugs, including CDK4/6 inhibitors for metastatic breast cancer and immunotherapies for melanoma.
His areas of expertise include endocrine therapy, managing hormone resistance, and developing new immunotherapies. Dr. Soberino is known for his patient-centered care. He actively collaborates in research to improve cancer treatment. He is accredited by VHIO and is a key member of the Breast Cancer and Melanoma Units.